Brinter and LED Tailor Partner

To implement an automatic photon disinfection system in the 3D bioprinter chamber

What To Know

  • “The partnership with LED Tailor makes Brinter the first 3D bioprinter in the world using blue light disinfection technology that can be utilized both inside and outside of the device to clean the environment around the bioprinter,” says Tomi Kalpio, CEO at Brinter.
  • Customers of Brinter include bio and pharmaceutical companies like Nanoform, as well as research organizations like VTT, BEST group at the University of Glasgow, Johannes Gutenberg University of Mainz, the University of Oulu, University of Turku, Åbo Akademi, Tampere University, and the University of Helsinki.

Bioprinting startup Brinter has today announced a partnership with LED Tailor to introduce a new disinfecting blue light feature embedded in its multi-material 3D bioprinting solution Brinter®. The system enables the safe production of e.g. tissue models and drugs, and minimizes the need for separate cleanrooms, making bioprinters more portable and safe.

Brinter is a modular bioprinter that is able to print multi-material and highly complex tissue structures in 3D, providing advanced features needed for bioprinting. The device can print both stiff and soft materials, including but not limited to liquids and hydrogels with living cells, bio-paste, metal with binder material, and thermoplastics, while being easy to set up in a lab in minutes.

Blue light is a part of the visible light spectrum, from 400 nm to approximately 500 nm wavelength. Disinfecting blue light, while being completely safe for human beings, kills all forms of bacteria, yeast, and mold. Opposite to UV-light (100–400nm), visible blue light does not deteriorate materials or cause other hazardous effects.

The discovery that all microbes contain blue light-sensitive compounds inside their cells as a part of their natural metabolism has been the key to creating this effective disinfection system.

When these light-sensitive compounds are exposed to specific wavelengths of disinfecting blue light with a certain light intensity, a destructive chemical reaction starts. The end products of this reaction are reactive oxygen radicals inside the microbial cell. Reactive oxygen species (ROS) are molecules containing a very reactive oxygen component, which has the ability to cause damage to any structure inside the microbial cell and destroy it from the inside.

“Our photon disinfection innovation is an automatic and sustainable solution to microbe problems. The system enables safe bioprinting, production of food and beverages, restrains epidemics, and answers the needs of cleanrooms. Our solutions improve safety and vitality of employees and reduce microbiological and chemical risks in healthcare and industrial sites,” says Harri Rautio, CEO at LED Tailor.

“The partnership with LED Tailor makes Brinter the first 3D bioprinter in the world using blue light disinfection technology that can be utilized both inside and outside of the device to clean the environment around the bioprinter,” says Tomi Kalpio, CEO at Brinter.

Customers of Brinter include bio and pharmaceutical companies like Nanoform, as well as research organizations like VTT, BEST group at the University of Glasgow, Johannes Gutenberg University of Mainz, the University of Oulu, University of Turku, Åbo Akademi, Tampere University, and the University of Helsinki.

To date, Brinter is currently active in over 10 countries, including the USA, Germany, India, and the UK. Last month, the company recently launched its new entry-level model, Brinter Core.

SourceBrinter
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version